FindTrial
Sign In

Study on the value of microRNA-222 in diagnosis and prognosis evaluation of patients with acute myocardial infarction

Study on the value of microRNA-222 in diagnosis and prognosis evaluation of patients with acute myocardial infarction

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039412
Enrollment
Unknown
Registered
2020-10-27
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases

Interventions

Gold Standard:1. cTnI 2. Clinical outcome
Index test:1.&#32
microRNA-222 2.&#32
Risk&#32
prediction&#32
model&#32
post&#32
myocardial&#32
infarction

Sponsors

Shanghai Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients older than 18 years old; 2. Patients with acute myocardial infarction; 3. Patients with chest pain less than 12 hours.

Exclusion criteria

Exclusion criteria: Patients without informed consent.

Design outcomes

Primary

MeasureTime frame
SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactChen Wei

Shanghai Tongji Hospital

chenwei_17@126.com+86 18016070916

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026